Document is current
Any future updates will be listed below
-
Authors
Xu, Jing
Keenan, Tanya E.
Overmoyer, Beth
Tung, Nadine M.
Gelman, Rebecca S.
Habin, Karleen
Garber, Judy E.
Ellisen, Leif W.
Winer, Eric P.
Goss, Paul E.
Yeap, Beow Y.
Chabner, Bruce A. https://orcid.org/0000-0002-6306-2802
Isakoff, Steven J.
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 22 February 2021
Accepted: 13 June 2021
First Online: 20 August 2021
Declarations
:
: The corresponding author SJI has received institutional research funding and consulting fees from Abbvie. JX, TEK, BO, NMT, RSG, KH, JEG, LWE, EPW, PEG, BYY, and BAC report no conflicts of interest to this study.
: The study protocol and informed consent form were reviewed and approved by the Dana-Farber/Harvard Cancer Center (DF/HCC) institutional review board. This study was performed in accordance to the Declaration of Helsinki and International Conference on Harmonization (ICH) Good Clinical Practice (GCP) guidelines.
: Written informed consent was obtained from all patients involved in the study before any study procedure.
